Nalmefene in Alcohol Dependence and Borderline Personality Disorder

F

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Status

Unknown

Conditions

Borderline Personality Disorder
Alcohol Use Disorder

Treatments

Drug: Nalmefene

Study type

Interventional

Funder types

Other

Identifiers

NCT02752503
IIBSP-NAL-2014-76

Details and patient eligibility

About

The objective is to study the effectiveness of Nalmefene in decreasing alcohol intake in subjects with alcohol use disorder and comorbid BPD.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Alcohol use disorder according to DSM 5
  • Borderline personality disorder according to DSM 5
  • CGI-BPD > 3
  • Female have to use contraception

Exclusion criteria

  • Other axis I disorders
  • Severe organic disorder
  • Pregnancy or breastfeeding
  • Allergy to Nalmefene
  • Subjects with Opioids use disorder or in treatment with opioid agonists

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Nalmafene
Experimental group
Treatment:
Drug: Nalmefene

Trial contacts and locations

1

Loading...

Central trial contact

Juan C Pascual, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems